000 01513 a2200421 4500
005 20250518061609.0
264 0 _c20200629
008 202006s 0 0 eng d
022 _a1750-1172
024 7 _a10.1186/s13023-019-1197-z
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHoyer-Kuhn, Heike
245 0 0 _aIndividualized treatment with denosumab in children with osteogenesis imperfecta - follow up of a trial cohort.
_h[electronic resource]
260 _bOrphanet journal of rare diseases
_c09 2019
300 _a219 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aBone Density
_xdrug effects
650 0 4 _aBone Density Conservation Agents
_xtherapeutic use
650 0 4 _aChild
650 0 4 _aCollagen Type I
_xgenetics
650 0 4 _aCollagen Type I, alpha 1 Chain
650 0 4 _aDenosumab
_xtherapeutic use
650 0 4 _aDiphosphonates
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aHypercalciuria
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMutation
_xgenetics
650 0 4 _aOsteogenesis Imperfecta
_xdrug therapy
650 0 4 _aRetrospective Studies
700 1 _aRehberg, Mirko
700 1 _aNetzer, Christian
700 1 _aSchoenau, Eckhard
700 1 _aSemler, Oliver
773 0 _tOrphanet journal of rare diseases
_gvol. 14
_gno. 1
_gp. 219
856 4 0 _uhttps://doi.org/10.1186/s13023-019-1197-z
_zAvailable from publisher's website
999 _c30124493
_d30124493